631 participants
Topical Ruxolitinib Evaluation in Atopic Dermatitis Study 1 (TRuE AD1) - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2023-09-28
- Start Date:
- 2018-12-20
- Completion:
- 2019-12-23
Conditions
- Atopic Dermatitis
Interventions
- DRUG